1. Home
  2. VIAV vs PTGX Comparison

VIAV vs PTGX Comparison

Compare VIAV & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Viavi Solutions Inc.

VIAV

Viavi Solutions Inc.

HOLD

Current Price

$50.24

Market Cap

7.7B

Sector

Technology

ML Signal

HOLD

Logo Protagonist Therapeutics Inc.

PTGX

Protagonist Therapeutics Inc.

HOLD

Current Price

$112.02

Market Cap

6.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VIAV
PTGX
Founded
1923
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.7B
6.4B
IPO Year
1996
2016

Fundamental Metrics

Financial Performance
Metric
VIAV
PTGX
Price
$50.24
$112.02
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
13
Target Price
$32.66
$108.23
AVG Volume (30 Days)
6.1M
511.9K
Earning Date
04-29-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
225.00
N/A
EPS
N/A
0.05
Revenue
$1,084,300,000.00
N/A
Revenue This Year
$37.78
$874.25
Revenue Next Year
$10.64
N/A
P/E Ratio
N/A
$2,215.80
Revenue Growth
8.39
N/A
52 Week Low
$9.28
$49.86
52 Week High
$60.43
$113.66

Technical Indicators

Market Signals
Indicator
VIAV
PTGX
Relative Strength Index (RSI) 50.79 61.93
Support Level $44.41 $94.48
Resistance Level $54.68 N/A
Average True Range (ATR) 4.26 4.90
MACD -0.10 1.42
Stochastic Oscillator 44.83 88.98

Price Performance

Historical Comparison
VIAV
PTGX

About VIAV Viavi Solutions Inc.

Viavi Solutions Inc. is an international provider of network test, monitoring, and assurance solutions to communications service providers, enterprises, network equipment manufacturers, civil government, military and avionics customers. The company also offers high-performance thin-film optical coatings, providing light management solutions to anti-counterfeiting, 3D sensing, electronics, automotive, defense, and instrumentation markets. Its operating segments include Network Enablement, Service Enablement, and Optical Security and Performance Products. Geographically, it derives a majority of its revenue from the United States. Additionally, it manufactures and sells optical filters for 3D sensing products that allow facial recognition security authentication for mobile devices.

About PTGX Protagonist Therapeutics Inc.

Protagonist Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of peptide-based therapeutics using its proprietary technology platform. The company focuses on three therapeutic areas: inflammation and immunology, hematology, and metabolic diseases. Its pipeline includes clinical-stage and preclinical candidates such as rusfertide for polycythemia vera, icotrokinra for inflammatory diseases, and other programs targeting IL-17, obesity, and iron metabolism disorders, developed through internal research and strategic collaborations.

Share on Social Networks: